Home Medical problems in patients with chronic kidney disease undergoing hemodialysis and their therapy
Article
Licensed
Unlicensed Requires Authentication

Medical problems in patients with chronic kidney disease undergoing hemodialysis and their therapy

  • Budi Suprapti EMAIL logo , Wenny Putri Nilamsari , Rachmania , Widodo and Chris Alderman
Published/Copyright: November 20, 2019

Abstract

Background

It was reported that hemodialysis (HD) with either a new or reused dialyzer raises medical problems that require therapeutic regimens. This study aimed to investigate the medical problems and their management in patients undergoing HD.

Methods

This study was conducted by prospectively observing patients with chronic kidney disease undergoing HD. The incidence of medical problems and the treatment given were recorded.

Results

Among 351 cases of HD, medical problems occurred in 15.7% of cases, including hypotension as the most dominant, followed by muscle cramps, shivering, headache, asphyxia, fever, chest pain, and pruritus. Hypotension was ameliorated with intravenous 40% dextrose and normal saline. Muscle cramps were overcome with 40% dextrose, normal saline, methampyrone, and calcium gluconate. Shivering was managed by warming the patients followed by intravenous methampyrone, 40% dextrose, and normal saline. Meanwhile, headache was reduced by paracetamol or intravenous methampyrone and 40% dextrose. Fever was treated by intravenous methampyrone or oral paracetamol. Pruritus was managed by intravenous dexamethasone and diphenhydramine.

Conclusions

Medical problems occurring during HD are prevalent and need immediate therapy. Pharmacists and clinicians should work in collaboration to improve the patients’ quality of life.

  1. Research funding: None declared.

  2. Author contributions: All of the authors contributed to the design of the study, the acquisition and interpretation of the data, and critical revision of manuscript. All authors have accepted responsibility for the entire content of this manuscript and approved its submission.

  3. Competing interests: Authors state no conflict of interest.

  4. Informed consent: Informed consent was obtained from all individuals included in this study.

  5. Ethical approval: Research involving human subjects complied with all relevant national regulations, institutional policies and is in accordance with the tenets of the Helsinki Declaration (as revised in 2013), and has been approved by the authors’ institutional review board (46/Panke.KKE/11/II/2010).

References

[1] Kasper DL, Braunwald E, Fauci AS, Hauser SL, Longo DL, Jameson JL. Renal disease. Harrison’s manual of medicine, 16th ed. New York: McGraw Hill, 2005:699–708.Search in Google Scholar

[2] Bakri S. Deteksi Dini dan Upaya-Upaya Pencegahan Progresivitas Penyakit Ginjal Kronik: Supplement, vol. 26, no. 3, July-September 2005, Depkes RI, 2007. Jumlah Penderita Penyakit Ginjal. Available at: www.depkes.go.ac. Accessed: December 2009.Search in Google Scholar

[3] Elwell RJ, Foote EF. Hemodialysis and peritoneal dialysis. In: DiPiro JT, editor. Pharmacotherapy a pathophysiologic approach, 6th ed. New York: The McGraw-Hill Companies Inc., 2005:851–6.Search in Google Scholar

[4] Davenport A. Intradialytic complications during hemodialysis. Hemodial Int 2006;10:162–7.10.1111/j.1542-4758.2006.00088.xSearch in Google Scholar PubMed

[5] Agustriadi O, Suwitra K, Widiana GR, Sudhana W, Loekman JS, Kandarini Y. Hubungan antara Perubahan Volume Darah Relatif dengan Hipotensi Intradialitik selama Hemodialisis pada Gagal Ginjal Kronik. J Peny Dalam 2009;10:99–109.Search in Google Scholar

[6] Erstad BL. Hypovolemic shock. In: DiPiro JT, editor. Pharmacotherapy a pathophysiologic approach, 7th ed. New York: The McGraw-Hill Companies Inc., 2008:441.Search in Google Scholar

[7] Daurdigas JT, Blake PG, Ing TS. Handbook of dialysis, 3rd ed. Philadelphia: Lippincott Williams & Wilkins, 2001:61.148–57.Search in Google Scholar

[8] Levin NW, Ronco C. Complications during hemodialysis: common clinical problems during hemodialysis. In: Nissenson AR, editor. Dialysis therapy, 3rd ed. Philadelphia: Hanley & Belfus Inc., 2002:171–9.Search in Google Scholar

[9] Anderson PO, Knoben JE, Troutman WG. Handbook of clinical drug data, 10th ed. New York: The McGraw-Hill Companies Inc., 2002:734.Search in Google Scholar

[10] Lacy CF, Armstrong LL, Goldman MP, Lance LL. Drug information handbook, 18th ed. New York: Lexi-Comp. Inc., 2009:456.Search in Google Scholar

[11] Lacson E, Lazarus M. Dialyzer best practice: single use or reuse? Semin Dial 2006;19:120–8.10.1111/j.1525-139X.2006.00137.xSearch in Google Scholar PubMed

[12] Murthy BV, Molony DA. Reprocessing of hemodialyzer. In: Pereira BJG, editor. Chronic kidney disease, dialysis and transplantation, 2nd ed. Philadelphia: Elsevier Inc., 2005:395.10.1016/B978-1-4160-0158-4.50023-9Search in Google Scholar

Received: 2019-09-05
Accepted: 2019-10-03
Published Online: 2019-11-20

© 2019 Walter de Gruyter GmbH, Berlin/Boston

Articles in the same Issue

  1. Reviews
  2. Pharmacist contributions in the treatment of diabetes mellitus in Southeast Asia: a narrative review
  3. The implementation of a chronic disease management program (Prolanis) in Indonesia: a literature review
  4. Original Articles
  5. Quercetin attenuates acute predator stress exposure-evoked innate fear and behavioral perturbation
  6. Evaluating current practices and policies in the use of injectable medicines for treating myalgia in a primary care center in Pamekasan, Indonesia
  7. The contemporary role and potential of pharmacist contribution for community health using social media
  8. Evaluation of rational drug use based on World Health Organization prescribing indicators in a primary care center in Pamekasan East Java, Indonesia
  9. The prescription patterns of second-generation antipsychotics in schizophrenia outpatient setting
  10. Factors affecting community pharmacist’s service for women with chronic diseases during pregnancy and breastfeeding: application of the Health Belief Model
  11. Overview of therapeutic changes in antiepileptic drugs in adult patients
  12. Exploration of barriers affecting job satisfaction among community pharmacists
  13. Patients’ characteristics and their adherence to insulin therapy
  14. Correlation of chemotherapy costs with quality of life in nasopharyngeal cancer patients
  15. Impact of educational preeclampsia prevention booklet on knowledge and adherence to low dose aspirin among pregnant women with high risk for preeclampsia
  16. Translation, cultural adaptation, and validation of the quality of well being self-administered questionnaire in general population in Indonesia
  17. Knowledge, attitude, and practice of pharmacists towards management of hypertension in primary care centers
  18. Medication adherence in diabetes mellitus patients at Tanjung Karang Primary Health Care Center, Mataram
  19. Decreasing angiogenesis vasa vasorum through Lp-PLA2 and H2O2 inhibition by PSP from Ganoderma lucidum in atherosclerosis: in vivo diabetes mellitus type 2
  20. Antiaggregation effect of clopidogrel in coronary heart disease patients using omeprazole
  21. The effect of curcuma (Curcuma xanthorrizha roxb.) extract as an adjuvant of captopril therapy on cardiac histopathology of male mice (Mus musculus) with hypertension
  22. Coenzyme Q10 nanostructured lipid carriers as an inducer of the skin fibroblast cell and its irritability test in a mice model
  23. Medical problems in patients with chronic kidney disease undergoing hemodialysis and their therapy
  24. ADMET properties of novel 5-O-benzoylpinostrobin derivatives
  25. Development of nonalcoholic fatty liver disease model by high-fat diet in rats
  26. Molecular docking of novel 5-O-benzoylpinostrobin derivatives as wild type and L858R/T790M/V948R mutant EGFR inhibitor
  27. The relationship between the level of education and accuracy of insulin injection techniques in DM patients with measurement of HbA1c values
  28. The effect of premixed insulin to blood glucose concentration in patients with type 2 diabetes mellitus
  29. Intravenous insulin therapy in diabetes mellitus with hyperglycemic crisis and intercurrent illness
  30. Adherence behavior assessment of oral antidiabetic medication use: a study of patient decisions in long-term disease management in primary health care centers in Surabaya
  31. Evaluation to the chemotherapy use in patients with diffuse large B-cell lymphoma
  32. Analysis of the use and cost of stress ulcer prophylaxis for surgical inpatients
  33. Antineuroinflammation activity of n-butanol fraction of Marsilea crenata Presl. in microglia HMC3 cell line
  34. The enhancement of Arg1 and activated ERβ expression in microglia HMC3 by induction of 96% ethanol extract of Marsilea crenata Presl. leaves
  35. Ternary solid dispersion to improve solubility and dissolution of meloxicam
  36. Improving solubility and dissolution of meloxicam by solid dispersion using hydroxypropyl methylcellulose 2910 3 cps and nicotinamide
  37. o-Hydroxycinnamic derivatives as prospective anti-platelet candidates: in silico pharmacokinetic screening and evaluation of their binding sites on COX-1 and P2Y12 receptors
  38. The change of proinflammatory cytokine tumor necrosis factor α level in the use of meloxicam in rat model of osteoarthritis
  39. Attenuation of IL-1ß on the use of glucosamine as an adjuvant in meloxicam treatment in rat models with osteoarthritis
  40. Analysis of effectiveness and drug related problems of pain reliever for knee osteoarthritis: weighing clinical risk and benefit
  41. Comparison of antibiotic prescriptions in adults and children with upper respiratory tract infections in Bangka Tengah primary health care centers
  42. Profile of sociodemographics, sources of infection, antiretrovirals and CD4 counts on HIV/AIDS outpatients in Turen Primary Health Centre, Indonesia
  43. Synergistic anti-hepatitis C virus activity of Ruta angustifolia extract with NS3 protein inhibitor
  44. In vitro equivalence of generic and branded amoxicillin tablet by microbiological assay method
  45. Knowledge and attitude: two fundamental factors that determine patient compliance in antibiotic therapy
  46. Molecular docking study of sappan wood extract to inhibit PBP2A enzyme on methicillin-resistant Staphylococcus aureus (MRSA)
  47. Effect of curcumin analogue synthetic product from cullilawan oil for the liver damage treatment in male mice (Mus musculus L.)
  48. Case Report
  49. A case report of generalized tetanus in a 42-year-old man with dental infection
Downloaded on 10.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/jbcpp-2019-0250/html
Scroll to top button